Riptide Bioscience is focused on developing innovative therapeutics that leverage the natural defense mechanisms of the human body, specifically through the use of Host Defense Peptides (HDPs). These small proteins play a crucial role in the immune response, particularly in combating microbial infections and regulating inflammation. Riptide's research has led to the identification of key structures within naturally occurring HDPs, which have been engineered using proprietary methods to create peptides that exhibit significantly enhanced efficacy compared to their natural counterparts. This approach aims to provide effective treatments for acute infections and to manage chronic inflammatory conditions.

The company has established a strong foundation for its engineered peptide therapeutics through collaborations with academic institutions and support from various government research programs, including those from the Department of Defense and the National Cancer Institute. Riptide Bioscience is actively seeking partnerships with pharmaceutical companies to further explore the potential of its proprietary drug candidates, highlighting its commitment to advancing the development of medicines with lifesaving potential.

United States

Riptide Bioscience is developing medicines with lifesaving potential, using strategies common to almost all organisms. Like most plants and animals,

Riptide Bioscience

Company Details